You are here

FSD Pharma Inc. Subordinate Voting Shares

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
HUGE
CSE Index: 
Currency: 

FSD Pharma is targeting all legal aspects of the cannabis industry, including cultivation, processing, manufacturing, extracts and research and development.

FSD is a licensed producer of cannabis under the Cannabis Act. The Company received its cultivation license on October 13, 2017. An amendment to the licence effective November 8, 2018, allows the Company to sell cannabis to other licensed producers. On February 19, 2019, the Company received its Standard Processing License, which is required for any facility that is processing more than the equivalent of 600 kg of dried flowers per year.

FSD is a science driven company with a mission to leverage the largest hydroponic indoor cannabis facility in the world to research and develop life-saving medicines based on cannabinoid science.

FSD is planning for a stage-phased development at its primary location in Cobourg, Ontario. Currently, the Company has 25,000 square feet of grow space available. Once completed, the facility is expected to have 3,800,000 sq. ft. of cultivation and related ancillary businesses.

You are here

FSD Pharma Inc. Subordinate Voting Shares (HUGE)

SEDAR Information

Company Info

Address
520 William Street
Cobourg, ON K9A 3A5
Canada
Email
donal.carroll@fvpharma.com
Website
http://www.fsdpharma.com
Listing date
Tuesday, May 29, 2018
Transfer Agent
Computershare Investor Services Inc.
Investor Relations
Sandra Huard
Email
sandralhuard@gmail.com
Auditor
UHY McGovern Hurley LLP

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
1,390,139,953
Reserved for Issuance: 
195,188,376
Total equity shares, as if converted: 
1,585,327,229

Company Officers

Dr. Raza Bokhari, Interim Chief Executive Officer and Co-Chairman - FSD Pharma Inc.
Anthony Durkacz, Co-Chairman - FSD Pharma Inc.
Zeeshan Saeed, President - FSD Pharma Inc.
Donal Carroll, Chief Financial Officer
Dr. Sara May, President - FV Pharma Inc.

Bulletins

28/05/2018

2018-0527 – New Listing – FSD Pharma Inc. (HUGE)

Le 28 mai/May 2018

The Class B Subordinate Voting Shares of FSD Pharma Inc. have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com  on the trading date.

Advertisement

Publicité

Latest CSE News

Upcoming Events

05_28_Issues_Changes_Capital_Markets_Website

CSE Talks Issues & Changes in the Capital Markets

Tuesday, May 28, 2019 -
2:45pm to 5:00pm
06_05_TakeStock_Alberta_Website_v2

TakeStock Alberta

Wednesday, June 5, 2019 -
8:30am to 5:30pm
06_06_Montreal_F1_GrandPrix_Website

CSE and Paul Benwell & Associates Montreal F1 Grand Prix

Thursday, June 6, 2019 -
5:00pm to 8:00pm